JPRN-UMIN000036908
Recruiting
未知
A dementia study by 11C-PiB, 18F-FDG PET - A dementia study by 11C-PiB, 18F-FDG PET
agoya City Rehabilitation Agency0 sites150 target enrollmentMay 31, 2019
Conditionsmild cognitive impairment, Alzheimer's disease, dementia with Lewy bodies, cerebrovascular dementia, frontotemporal degeneration, progressive supranuclear palsy, corticobasal degeneration, Parkinson's disease with dementia, other neurodegenerative diseases, normal pressure hydrocephalus, hypoxic encephalopathy, brain tumor, brain injury etc.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- mild cognitive impairment, Alzheimer'
- Sponsor
- agoya City Rehabilitation Agency
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Persons with other serious illnesses or unstable conditions, 2\. Persons suffering from deformities / disorders of spine or hip with pain in resting position, 3\. Persons judged inappropriate by doctor or the chief researcher
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
PIB PET study for dementia pathophysiology and diagnosisdementiaJPRN-UMIN000005642Kinki University Faculty of Medicine125
Not yet recruiting
Not Applicable
Diagnosis of Alzheimer disease using 11C-PIB PETAlzheimer's diseaseJPRN-UMIN000015607kyushu university hospital100
Completed
Not Applicable
Risk of Developing Dementia and Associated Factors in Patients With Normal Brain FDG PETNeurodegenerative DiseasesCognitive DisorderNCT04804722Central Hospital, Nancy, France100
Completed
Not Applicable
sefulness of 11PiB PET/CT in patients with dementiaDementiaJPRN-UMIN000010852ational center of neurology and Psychiatry100
Completed
Not Applicable
Clinical study for degenerative dementiaCorticobasal syndrome, Primary progressive aphasia, Dementia with Lewy bodiesJPRN-UMIN000014098Juntendo University school of Medicine Department of Diagnosis, Prevention and Treatment of Dementia150